Sexual Health & Medical Wellness Chlamydia Pneumoniae Infection Linked to Alzheimer’s Disease Progression, Opening New Avenues for Treatment and Early Detection July 8, 2026 Susilo Ahmad A groundbreaking study conducted by researchers at Cedars-Sinai has revealed a compelling connection between a common respiratory bacterium, Chlamydia pneumoniae, and the progression of Alzheimer’s disease. The findings, published in…
Psychology & Intimacy New Research Challenges Long-Held Assumptions in Cerebellar Neuroscience, Potentially Reshaping Treatment for Neurological Disorders July 3, 2026 Rebecca Shoemaker New research from a Virginia Tech neuroscientist at the Fralin Biomedical Research Institute at VTC is raising questions about a long-standing approach to studying chronic neurological conditions such as dystonia,…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Single-Dose Oral Treatment Against Growing Threat of Drug-Resistant Gonorrhea June 25, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness Chlamydia Pneumoniae Implicated in Alzheimer’s Progression, Opening New Avenues for Treatment and Early Detection June 15, 2026 Susilo Ahmad A groundbreaking study by researchers at Cedars-Sinai has revealed a compelling connection between a common respiratory bacterium, Chlamydia pneumoniae, and the development and progression of Alzheimer’s disease. The findings, published…
Psychology & Intimacy Immunotherapy Offers Promising New Avenue for Treatment-Resistant Depression, University of Bristol Study Reveals June 4, 2026 Rebecca Shoemaker A groundbreaking clinical trial led by researchers at the University of Bristol has unveiled a potentially transformative approach to treating difficult-to-manage depression, suggesting that immunotherapy could offer a novel therapeutic…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Single-Dose Oral Treatment for Gonorrhea Amid Rising Antibiotic Resistance June 4, 2026 Susilo Ahmad In a significant development poised to revolutionize the treatment of gonorrhea, researchers have unveiled compelling results for a new oral medication named zoliflodacin. This novel antibiotic, designed to combat increasingly…
Sexual Health & Medical Wellness Chlamydia Pneumoniae Infection Linked to Alzheimer’s Disease Progression, Opening New Avenues for Treatment and Early Diagnosis. May 31, 2026 Susilo Ahmad A groundbreaking study conducted by researchers at Cedars-Sinai has revealed a significant connection between a common respiratory bacterium, Chlamydia pneumoniae, and the progression of Alzheimer’s disease. The findings, published in…
Psychology & Intimacy Immunotherapy Shows Promise as a Novel Approach for Treatment-Resistant Depression May 28, 2026 Rebecca Shoemaker A groundbreaking clinical trial led by the University of Bristol suggests that immunotherapy, a treatment modality traditionally employed for conditions like cancer and autoimmune diseases, could offer a transformative new…
Sexual Health & Medical Wellness Zoliflodacin Emerges as Promising Single-Dose Oral Treatment for Drug-Resistant Gonorrhea Following Successful Phase 3 Clinical Trials May 28, 2026 Susilo Ahmad Researchers are poised to revolutionize the treatment landscape for gonorrhea with the successful completion of a late-stage phase 3 clinical trial for a novel oral medication, zoliflodacin. Published in the…
Psychology & Intimacy Restoring Cellular Energy: Duke Researchers Uncover Promising New Avenue for Chronic Nerve Pain Treatment May 24, 2026 Rebecca Shoemaker Millions worldwide grapple with the debilitating reality of chronic nerve pain, a condition where even the gentlest touch can ignite an agonizing, unbearable sensation. For decades, the scientific community has…
